The Prognostic Effect of IKZF1 Deletions in ETV6::RUNX1 and High Hyperdiploid Childhood Acute Lymphoblastic Leukemia
IKZF1 deletions are an established prognostic factor in childhood acute lymphoblastic leukemia (ALL). However, their relevance in patients with good risk genetics, namely ETV6::RUNX1 and high hyperdiploid (HeH), ALL remains unclear. We assessed the prognostic impact of IKZF1 deletions in 939 ETV6::R...
| Main Authors: | , , , , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2023-05-01
|
| Series: | HemaSphere |
| Online Access: | http://journals.lww.com/10.1097/HS9.0000000000000875 |
| _version_ | 1827331184939499520 |
|---|---|
| author | Anna Østergaard Amir Enshaei Rob Pieters Ajay Vora Martin A. Horstmann Gabriele Escherich Bertil Johansson Mats Heyman Kjeld Schmiegelow Peter M. Hoogerbrugge Monique L. den Boer Roland P. Kuiper Anthony V. Moorman Judith M. Boer Frank N. van Leeuwen |
| author_facet | Anna Østergaard Amir Enshaei Rob Pieters Ajay Vora Martin A. Horstmann Gabriele Escherich Bertil Johansson Mats Heyman Kjeld Schmiegelow Peter M. Hoogerbrugge Monique L. den Boer Roland P. Kuiper Anthony V. Moorman Judith M. Boer Frank N. van Leeuwen |
| author_sort | Anna Østergaard |
| collection | DOAJ |
| description | IKZF1 deletions are an established prognostic factor in childhood acute lymphoblastic leukemia (ALL). However, their relevance in patients with good risk genetics, namely ETV6::RUNX1 and high hyperdiploid (HeH), ALL remains unclear. We assessed the prognostic impact of IKZF1 deletions in 939 ETV6::RUNX1 and 968 HeH ALL patients by evaluating data from 16 trials from 9 study groups. Only 3% of ETV6::RUNX1 cases (n = 26) were IKZF1-deleted; this adversely affected survival combining all trials (5-year event-free survival [EFS], 79% versus 92%; P = 0.02). No relapses occurred among the 14 patients with an IKZF1 deletion treated on a minimal residual disease (MRD)-guided protocols. Nine percent of HeH cases (n = 85) had an IKZF1 deletion; this adversely affected survival in all trials (5-year EFS, 76% versus 89%; P = 0.006) and in MRD-guided protocols (73% versus 88%; P = 0.004). HeH cases with an IKZF1 deletion had significantly higher end of induction MRD values (P = 0.03). Multivariate Cox regression showed that IKZF1 deletions negatively affected survival independent of sex, age, and white blood cell count at diagnosis in HeH ALL (hazard ratio of relapse rate [95% confidence interval]: 2.48 [1.32-4.66]). There was no evidence to suggest that IKZF1 deletions affected outcome in the small number of ETV6::RUNX1 cases in MRD-guided protocols but that they are related to higher MRD values, higher relapse, and lower survival rates in HeH ALL. Future trials are needed to study whether stratifying by MRD is adequate for HeH patients or additional risk stratification is necessary. |
| first_indexed | 2024-03-07T16:32:28Z |
| format | Article |
| id | doaj.art-5645c5c18f97430d84ab7aaaba94a6bf |
| institution | Directory Open Access Journal |
| issn | 2572-9241 |
| language | English |
| last_indexed | 2024-03-07T16:32:28Z |
| publishDate | 2023-05-01 |
| publisher | Wiley |
| record_format | Article |
| series | HemaSphere |
| spelling | doaj.art-5645c5c18f97430d84ab7aaaba94a6bf2024-03-03T10:09:25ZengWileyHemaSphere2572-92412023-05-0175e87510.1097/HS9.0000000000000875202305000-00014The Prognostic Effect of IKZF1 Deletions in ETV6::RUNX1 and High Hyperdiploid Childhood Acute Lymphoblastic LeukemiaAnna Østergaard0Amir Enshaei1Rob Pieters2Ajay Vora3Martin A. Horstmann4Gabriele Escherich5Bertil Johansson6Mats Heyman7Kjeld Schmiegelow8Peter M. Hoogerbrugge9Monique L. den Boer10Roland P. Kuiper11Anthony V. Moorman12Judith M. Boer13Frank N. van Leeuwen141 Princess Máxima Center for Pediatric Oncology, Utrecht, Netherlands3 Leukaemia Research Cytogenetics Group, Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, United Kingdom1 Princess Máxima Center for Pediatric Oncology, Utrecht, Netherlands4 Department of Haematology, Great Ormond Street Hospital, London, United Kingdom5 Clinic of Pediatric Hematology and Oncology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany5 Clinic of Pediatric Hematology and Oncology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany7 Division of Clinical Genetics, Department of Laboratory Medicine, Lund University, Sweden9 Childhood Cancer Research Unit, Department of Women’s and Children’s Health, Karolinska Institutet, Stockholm, Sweden11 Department of Pediatrics and Adolescent Medicine, University Hospital Rigshospitalet, Institute of Clinical Medicine, Faculty of Medicine, University of Copenhagen, Denmark1 Princess Máxima Center for Pediatric Oncology, Utrecht, Netherlands1 Princess Máxima Center for Pediatric Oncology, Utrecht, Netherlands1 Princess Máxima Center for Pediatric Oncology, Utrecht, Netherlands3 Leukaemia Research Cytogenetics Group, Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, United Kingdom1 Princess Máxima Center for Pediatric Oncology, Utrecht, Netherlands1 Princess Máxima Center for Pediatric Oncology, Utrecht, NetherlandsIKZF1 deletions are an established prognostic factor in childhood acute lymphoblastic leukemia (ALL). However, their relevance in patients with good risk genetics, namely ETV6::RUNX1 and high hyperdiploid (HeH), ALL remains unclear. We assessed the prognostic impact of IKZF1 deletions in 939 ETV6::RUNX1 and 968 HeH ALL patients by evaluating data from 16 trials from 9 study groups. Only 3% of ETV6::RUNX1 cases (n = 26) were IKZF1-deleted; this adversely affected survival combining all trials (5-year event-free survival [EFS], 79% versus 92%; P = 0.02). No relapses occurred among the 14 patients with an IKZF1 deletion treated on a minimal residual disease (MRD)-guided protocols. Nine percent of HeH cases (n = 85) had an IKZF1 deletion; this adversely affected survival in all trials (5-year EFS, 76% versus 89%; P = 0.006) and in MRD-guided protocols (73% versus 88%; P = 0.004). HeH cases with an IKZF1 deletion had significantly higher end of induction MRD values (P = 0.03). Multivariate Cox regression showed that IKZF1 deletions negatively affected survival independent of sex, age, and white blood cell count at diagnosis in HeH ALL (hazard ratio of relapse rate [95% confidence interval]: 2.48 [1.32-4.66]). There was no evidence to suggest that IKZF1 deletions affected outcome in the small number of ETV6::RUNX1 cases in MRD-guided protocols but that they are related to higher MRD values, higher relapse, and lower survival rates in HeH ALL. Future trials are needed to study whether stratifying by MRD is adequate for HeH patients or additional risk stratification is necessary.http://journals.lww.com/10.1097/HS9.0000000000000875 |
| spellingShingle | Anna Østergaard Amir Enshaei Rob Pieters Ajay Vora Martin A. Horstmann Gabriele Escherich Bertil Johansson Mats Heyman Kjeld Schmiegelow Peter M. Hoogerbrugge Monique L. den Boer Roland P. Kuiper Anthony V. Moorman Judith M. Boer Frank N. van Leeuwen The Prognostic Effect of IKZF1 Deletions in ETV6::RUNX1 and High Hyperdiploid Childhood Acute Lymphoblastic Leukemia HemaSphere |
| title | The Prognostic Effect of IKZF1 Deletions in ETV6::RUNX1 and High Hyperdiploid Childhood Acute Lymphoblastic Leukemia |
| title_full | The Prognostic Effect of IKZF1 Deletions in ETV6::RUNX1 and High Hyperdiploid Childhood Acute Lymphoblastic Leukemia |
| title_fullStr | The Prognostic Effect of IKZF1 Deletions in ETV6::RUNX1 and High Hyperdiploid Childhood Acute Lymphoblastic Leukemia |
| title_full_unstemmed | The Prognostic Effect of IKZF1 Deletions in ETV6::RUNX1 and High Hyperdiploid Childhood Acute Lymphoblastic Leukemia |
| title_short | The Prognostic Effect of IKZF1 Deletions in ETV6::RUNX1 and High Hyperdiploid Childhood Acute Lymphoblastic Leukemia |
| title_sort | prognostic effect of ikzf1 deletions in etv6 runx1 and high hyperdiploid childhood acute lymphoblastic leukemia |
| url | http://journals.lww.com/10.1097/HS9.0000000000000875 |
| work_keys_str_mv | AT annaøstergaard theprognosticeffectofikzf1deletionsinetv6runx1andhighhyperdiploidchildhoodacutelymphoblasticleukemia AT amirenshaei theprognosticeffectofikzf1deletionsinetv6runx1andhighhyperdiploidchildhoodacutelymphoblasticleukemia AT robpieters theprognosticeffectofikzf1deletionsinetv6runx1andhighhyperdiploidchildhoodacutelymphoblasticleukemia AT ajayvora theprognosticeffectofikzf1deletionsinetv6runx1andhighhyperdiploidchildhoodacutelymphoblasticleukemia AT martinahorstmann theprognosticeffectofikzf1deletionsinetv6runx1andhighhyperdiploidchildhoodacutelymphoblasticleukemia AT gabrieleescherich theprognosticeffectofikzf1deletionsinetv6runx1andhighhyperdiploidchildhoodacutelymphoblasticleukemia AT bertiljohansson theprognosticeffectofikzf1deletionsinetv6runx1andhighhyperdiploidchildhoodacutelymphoblasticleukemia AT matsheyman theprognosticeffectofikzf1deletionsinetv6runx1andhighhyperdiploidchildhoodacutelymphoblasticleukemia AT kjeldschmiegelow theprognosticeffectofikzf1deletionsinetv6runx1andhighhyperdiploidchildhoodacutelymphoblasticleukemia AT petermhoogerbrugge theprognosticeffectofikzf1deletionsinetv6runx1andhighhyperdiploidchildhoodacutelymphoblasticleukemia AT moniqueldenboer theprognosticeffectofikzf1deletionsinetv6runx1andhighhyperdiploidchildhoodacutelymphoblasticleukemia AT rolandpkuiper theprognosticeffectofikzf1deletionsinetv6runx1andhighhyperdiploidchildhoodacutelymphoblasticleukemia AT anthonyvmoorman theprognosticeffectofikzf1deletionsinetv6runx1andhighhyperdiploidchildhoodacutelymphoblasticleukemia AT judithmboer theprognosticeffectofikzf1deletionsinetv6runx1andhighhyperdiploidchildhoodacutelymphoblasticleukemia AT franknvanleeuwen theprognosticeffectofikzf1deletionsinetv6runx1andhighhyperdiploidchildhoodacutelymphoblasticleukemia AT annaøstergaard prognosticeffectofikzf1deletionsinetv6runx1andhighhyperdiploidchildhoodacutelymphoblasticleukemia AT amirenshaei prognosticeffectofikzf1deletionsinetv6runx1andhighhyperdiploidchildhoodacutelymphoblasticleukemia AT robpieters prognosticeffectofikzf1deletionsinetv6runx1andhighhyperdiploidchildhoodacutelymphoblasticleukemia AT ajayvora prognosticeffectofikzf1deletionsinetv6runx1andhighhyperdiploidchildhoodacutelymphoblasticleukemia AT martinahorstmann prognosticeffectofikzf1deletionsinetv6runx1andhighhyperdiploidchildhoodacutelymphoblasticleukemia AT gabrieleescherich prognosticeffectofikzf1deletionsinetv6runx1andhighhyperdiploidchildhoodacutelymphoblasticleukemia AT bertiljohansson prognosticeffectofikzf1deletionsinetv6runx1andhighhyperdiploidchildhoodacutelymphoblasticleukemia AT matsheyman prognosticeffectofikzf1deletionsinetv6runx1andhighhyperdiploidchildhoodacutelymphoblasticleukemia AT kjeldschmiegelow prognosticeffectofikzf1deletionsinetv6runx1andhighhyperdiploidchildhoodacutelymphoblasticleukemia AT petermhoogerbrugge prognosticeffectofikzf1deletionsinetv6runx1andhighhyperdiploidchildhoodacutelymphoblasticleukemia AT moniqueldenboer prognosticeffectofikzf1deletionsinetv6runx1andhighhyperdiploidchildhoodacutelymphoblasticleukemia AT rolandpkuiper prognosticeffectofikzf1deletionsinetv6runx1andhighhyperdiploidchildhoodacutelymphoblasticleukemia AT anthonyvmoorman prognosticeffectofikzf1deletionsinetv6runx1andhighhyperdiploidchildhoodacutelymphoblasticleukemia AT judithmboer prognosticeffectofikzf1deletionsinetv6runx1andhighhyperdiploidchildhoodacutelymphoblasticleukemia AT franknvanleeuwen prognosticeffectofikzf1deletionsinetv6runx1andhighhyperdiploidchildhoodacutelymphoblasticleukemia |